BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11679587)

  • 1. Phosphatidylinositol 3-kinase p85 adaptor function in T-cells. Co-stimulation and regulation of cytokine transcription independent of associated p110.
    Kang H; Schneider H; Rudd CE
    J Biol Chem; 2002 Jan; 277(2):912-21. PubMed ID: 11679587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the Grb2- and phosphatidylinositol 3-kinase p85-binding p36/38 by Syk in Lck-negative T cells.
    von Willebrand M; Williams S; Tailor P; Mustelin T
    Cell Signal; 1998 Jun; 10(6):407-13. PubMed ID: 9720763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of phosphatidylinositol 3-kinase in NFAT activation in T cells.
    Jascur T; Gilman J; Mustelin T
    J Biol Chem; 1997 May; 272(22):14483-8. PubMed ID: 9162091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha.
    Turner SJ; Domin J; Waterfield MD; Ward SG; Westwick J
    J Biol Chem; 1998 Oct; 273(40):25987-95. PubMed ID: 9748276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
    Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
    PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
    Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
    J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation.
    Raab M; Pfister S; Rudd CE
    Immunity; 2001 Dec; 15(6):921-33. PubMed ID: 11754814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes.
    Gesbert F; Guenzi C; Bertoglio J
    J Biol Chem; 1998 Jul; 273(29):18273-81. PubMed ID: 9660791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).
    Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA
    Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
    Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
    J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
    Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
    Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.
    Katada T; Kurosu H; Okada T; Suzuki T; Tsujimoto N; Takasuga S; Kontani K; Hazeki O; Ui M
    Chem Phys Lipids; 1999 Apr; 98(1-2):79-86. PubMed ID: 10358930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p85/p110-type phosphatidylinositol kinase phosphorylates not only the D-3, but also the D-4 position of the inositol ring.
    Funaki M; Katagiri H; Kanda A; Anai M; Nawano M; Ogihara T; Inukai K; Fukushima Y; Ono H; Yazaki Y; Kikuchi M; Oka Y; Asano T
    J Biol Chem; 1999 Jul; 274(31):22019-24. PubMed ID: 10419527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p85 and p110 subunits of phosphatidylinositol 3-kinase-alpha are substrates, in vitro, for a constitutively associated protein tyrosine kinase in platelets.
    Geltz NR; Augustine JA
    Blood; 1998 Feb; 91(3):930-9. PubMed ID: 9446654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits.
    Holt KH; Olson L; Moye-Rowley WS; Pessin JE
    Mol Cell Biol; 1994 Jan; 14(1):42-9. PubMed ID: 8264609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation.
    Reddy SA; Huang JH; Liao WS
    J Immunol; 2000 Feb; 164(3):1355-63. PubMed ID: 10640750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cyclin D(1) expression and DNA synthesis by phosphatidylinositol 3-kinase in airway smooth muscle cells.
    Page K; Li J; Wang Y; Kartha S; Pestell RG; Hershenson MB
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):436-43. PubMed ID: 11017907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat.
    Tanaka N; Abe H; Yagita H; Okumura K; Nakamura M; Sugamura K
    Eur J Immunol; 1997 Apr; 27(4):834-41. PubMed ID: 9130632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.